Title: A2542
Official Title: 
Number of Sections: 1
Source: versions - Introduced Version
Media Type: text/html

================================================================================

Section 1:
A2542 ASSEMBLY, No. 2542 STATE OF NEW JERSEY 221st LEGISLATURE PRE-FILED FOR INTRODUCTION IN THE 2024 SESSION Sponsored by: Assemblyman  ERIK PETERSON District 23 (Hunterdon, Somerset and Warren) SYNOPSIS Provides sales and use tax exemption for purchases of rapid or laboratory tests for purposes of detecting infections. CURRENT VERSION OF TEXT Introduced Pending Technical Review by Legislative Counsel. An Act providing a sales and use tax exemption for sales of certain viral tests or antibody tests for purposes of detecting infections, supplementing P.L.1966, c.30 (C.54:32B-1 et seq.). Be It Enacted by the Senate and General Assembly of the State of New Jersey: 1.    Receipts from sales of rapid or laboratory viral tests or antibody tests, including, but not limited to, molecular and antigen tests, utilized for the purpose of detecting infections, such as SARS-CoV-2, are exempt from the tax imposed under the Sales and Use Tax Act, P.L.1966, c.30 (C.54:32B-1 et seq.). 2.    This act shall take effect immediately and apply to sales occurring on or after the first day of the second month next following enactment. STATEMENT This bill exempts from New Jersey sales and use tax purchases of rapid or laboratory viral tests or antibody tests.  The exemption will apply, but not be limited to, molecular and antigen tests utilized for detecting infections, such as SARS-CoV-2.


================================================================================

Raw Text:
A2542 ASSEMBLY, No. 2542 STATE OF NEW JERSEY 221st LEGISLATURE PRE-FILED FOR INTRODUCTION IN THE 2024 SESSION Sponsored by: Assemblyman  ERIK PETERSON District 23 (Hunterdon, Somerset and Warren) SYNOPSIS Provides sales and use tax exemption for purchases of rapid or laboratory tests for purposes of detecting infections. CURRENT VERSION OF TEXT Introduced Pending Technical Review by Legislative Counsel. An Act providing a sales and use tax exemption for sales of certain viral tests or antibody tests for purposes of detecting infections, supplementing P.L.1966, c.30 (C.54:32B-1 et seq.). Be It Enacted by the Senate and General Assembly of the State of New Jersey: 1.    Receipts from sales of rapid or laboratory viral tests or antibody tests, including, but not limited to, molecular and antigen tests, utilized for the purpose of detecting infections, such as SARS-CoV-2, are exempt from the tax imposed under the Sales and Use Tax Act, P.L.1966, c.30 (C.54:32B-1 et seq.). 2.    This act shall take effect immediately and apply to sales occurring on or after the first day of the second month next following enactment. STATEMENT This bill exempts from New Jersey sales and use tax purchases of rapid or laboratory viral tests or antibody tests.  The exemption will apply, but not be limited to, molecular and antigen tests utilized for detecting infections, such as SARS-CoV-2.